Alkem Laboratories

Price chart

Previous close

₹5,304.00

Open

₹5,340.00

Day high

₹5,475.00

Day low

₹5,312.50

Listed on NSE since 23 December 2015.

Futures and options

Futures, 23 Nov expiry

₹5,395.00

Premium to the share price

+11.00 (+0.20%)

Futures open interest

13,166 contracts (−55 today)

Lot size (NOV 26)

125 shares

Source: NSE, 09-Nov-2026 12:04:18, delayed. Option chain · All futures · Lot sizes

Pivot levels

R3

5,505.00

R2

5,401.00

R1

5,349.00

CPR top

5,271.00

Pivot

5,245.00

CPR bottom

5,219.00

S1

5,193.00

S2

5,089.00

S3

5,037.00

From Friday 6 November’s high, low and close (Yahoo Finance). Arithmetic on past prices, not a forecast.

Market value

₹63,417 Cr

P/E (trailing)

29.39

EPS (trailing)

₹180.44

Price to book

4.59

Dividend yield

0.38%

Debt to equity

0.14

Profit margin

14.3%

Beta

0.29

Volume today

1.20 L

Average volume

1.37 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Source: Alkem Laboratories’s results filed with NSE, consolidated (the whole group). Net profit is the share of Alkem Laboratories’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Alkem Laboratories’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti – infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Mumbai

Employees

19,346

Company website · Profile: Yahoo Finance

• Tech Query: Alkem Laboratories, Intellect Design Arena, Trent, SRF — What is the outlook? Where are these stocks headed?

  BusinessLine · 7 Nov, 22:14

• Dividend - Rs 10 Per Share

  Dividend · ex-date 7 August 2026

• Interim Dividend - Rs 43 Per Share

  Dividend · ex-date 20 February 2026

• Dividend - Rs 8 Per Share

  Dividend · ex-date 8 August 2025

• Interim Dividend - Rs 37 Per Share

  Dividend · ex-date 14 February 2025

• Dividend - Rs 5 Per Share

  Dividend · ex-date 9 August 2024 · record date 10 August 2024

• Interim Dividend - Rs 35 Per Share

  Dividend · ex-date 16 February 2024 · record date 17 February 2024

• Dividend - Rs 10 Per Share

  Dividend · ex-date 10 August 2023

• Interim Dividend - Rs 15 Per Share & Special Dividend Rs 25 Per Share

  Dividend · ex-date 17 February 2023 · record date 18 February 2023

Source: NSE. Latest first, 8 of 20.